FDA Inspection
Qilu Pharmaceutical (Hainan) Co. Ltd.Qilu Pharmaceutical (Hainan) Co. Ltd. – FDA Inspection, May 19, 2023
Record Details
This FDA Inspection record concerns Qilu Pharmaceutical (Hainan) Co. Ltd., with an inspection on May 19, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 6e8bd43e-ed93-47e5-874e-e0800b7e48d1
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1209088
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Qilu Pharmaceutical (Hainan) Co. Ltd.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| August 22, 2025 | Not classified | Office of Inspections and Investigations | |
| November 6, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 17, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 2, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 23, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Qilu Pharmaceutical (Hainan) Co. Ltd.
- FDA Inspection 1281926 - 2025-08-22
- FDA Inspection 1111054 - 2019-11-06
- FDA Inspection 1036684 - 2017-11-17
- FDA Inspection 984197 - 2016-08-02
- FDA Inspection 880306 - 2014-05-23
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.